To provide a pharmaceutical preparation used for treating inflammatory bowel disease (e.g. Crohn's disease or ulcerative colitis), dermal inflammation in the peripheral part of an artificial anus or a filtulous opening or an anal fistula of patients suffering from the Crohn's disease without special adverse effects such as causing of constipation.
This transrectal administration pharmaceutical preparation comprises active carbon as an active ingredient and is used for treating the inflammatory bowel disease, dermal inflammation in the peripheral part of the artificial anus or filtulous opening or the anal fistula of the patients suffering from the Crohn's disease. The active carbon is preferably spherical active carbon and the pharmaceutical preparation is preferably a suppository, a foaming agent or an enema agent.
